No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
REGN241220P770000
- 39.40
- +14.40+57.60%
15min DelayClose Dec 13 16:00 ET
39.40High39.40Low
39.40Open25.00Pre Close1 Volume11 Open Interest770.00Strike Price3.94KTurnover37.78%IV0.10%PremiumDec 20, 2024Expiry Date38.70Intrinsic Value100Multiplier4DDays to Expiry0.70Extrinsic Value100Contract SizeAmericanOptions Type-0.8852Delta0.0065Gamma18.24Leverage Ratio-0.5665Theta-0.0636Rho-16.14Eff Leverage0.1578Vega
Intraday
- 5D
- Daily
News
BofA Restarts Coverage of 11 Large-cap Biopharmas
Piper Sandler Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,195
Regeneron Pharmaceuticals (REGN): Sales Struggles and Future Prospects
B of A Securities Reinstates Underperform on Regeneron Pharmaceuticals, Announces $565 Price Target
Regeneron Pharmaceuticals Analyst Ratings
Regeneron Presents New And Updated Data For Odronextamab At ASH Annual Meeting